In subgroup analyses of patients with pSS according to anti-Ro/SSA antibody status and the SGUS score, no statistically significant difference was apparent, suggesting that skin barrier function was not associated with the immune profile or extent of major glandular duct damage caused by pSS.
← all excerpts
A pilot study of skin barrier function in patients with systemic sclerosis and primary Sjögren's syndrome.
1
—
—